These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22052652)

  • 1. The golden age of GPCR structural biology: any impact on drug design?
    Kolb P; Klebe G
    Angew Chem Int Ed Engl; 2011 Dec; 50(49):11573-5. PubMed ID: 22052652
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural diversity of G protein-coupled receptors and significance for drug discovery.
    Lagerström MC; Schiöth HB
    Nat Rev Drug Discov; 2008 Apr; 7(4):339-57. PubMed ID: 18382464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The family of G protein-coupled receptors: an example of membrane proteins.
    Tikhonova IG; Fourmy D
    Methods Mol Biol; 2010; 654():441-54. PubMed ID: 20665280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of structure of G-protein coupled receptors and of bound ligands, with applications for drug design.
    Li Y; Goddard WA
    Pac Symp Biocomput; 2008; ():344-53. PubMed ID: 18229698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.
    De Amici M; Dallanoce C; Holzgrabe U; Tränkle C; Mohr K
    Med Res Rev; 2010 May; 30(3):463-549. PubMed ID: 19557759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-protein-coupled receptor affinity prediction based on the use of a profiling dataset: QSAR design, synthesis, and experimental validation.
    Rolland C; Gozalbes R; Nicolaï E; Paugam MF; Coussy L; Barbosa F; Horvath D; Revah F
    J Med Chem; 2005 Oct; 48(21):6563-74. PubMed ID: 16220973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
    Filizola M; Weinstein H
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I want a new drug: G-protein-coupled receptors in drug development.
    Schlyer S; Horuk R
    Drug Discov Today; 2006 Jun; 11(11-12):481-93. PubMed ID: 16713899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein mapping gains a human focus.
    Ledford H
    Nature; 2010 Jul; 466(7306):544. PubMed ID: 20671686
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamics and flexibility of G-protein-coupled receptor conformations and their relevance to drug design.
    Vaidehi N
    Drug Discov Today; 2010 Nov; 15(21-22):951-7. PubMed ID: 20831898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-protein-coupled receptor heterodimerization: assay technologies to clinical significance.
    Kent T; McAlpine C; Sabetnia S; Presland J
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):580-9. PubMed ID: 17786857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational complexity of G-protein-coupled receptors.
    Kobilka BK; Deupi X
    Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design strategies for bivalent ligands targeting GPCRs.
    Shonberg J; Scammells PJ; Capuano B
    ChemMedChem; 2011 Jun; 6(6):963-74. PubMed ID: 21520422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development.
    Archbold JK; Flanagan JU; Watkins HA; Gingell JJ; Hay DL
    Trends Pharmacol Sci; 2011 Oct; 32(10):591-600. PubMed ID: 21722971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design.
    Gloriam DE; Foord SM; Blaney FE; Garland SL
    J Med Chem; 2009 Jul; 52(14):4429-42. PubMed ID: 19537715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class-B GPCR activation: is ligand helix-capping the key?
    Neumann JM; Couvineau A; Murail S; Lacapère JJ; Jamin N; Laburthe M
    Trends Biochem Sci; 2008 Jul; 33(7):314-9. PubMed ID: 18555686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-protein-coupled receptor allosterism: the promise and the problem(s).
    Christopoulos A; May LT; Avlani VA; Sexton PM
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):873-7. PubMed ID: 15494038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.